BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
[at noodls] – BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge New company to focus on oral drugs for hepatitis C and hereditary angioedema Combined HCV portfolio includes three complementary viral targeting … more
View todays social media effects on BCRX
View the latest stocks trending across Twitter. Click to view dashboard